AIM
NERV icon

Acrospire Investment Management’s Minerva Neurosciences NERV Stock Holding History

Acrospire Investment Management’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-630
Closed -$71K – 2346
2016
Q3 		$71K Sell
630
-88
-12% -$8.54K 0.05% 816
2016
Q2 		$59K Buy
+718
New +$45.6K 0.04% 925

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Acrospire Investment Management's NERV Position: Q4 2016 in Review

Acrospire Investment Management sold out of Minerva Neurosciences (NERV) in Q4 2016, closing a stake of 630 shares — an estimated $71K sold.

Acrospire Investment Management first reported a position in NERV in Q2 2016 and held it in 2 quarters. The position peaked at $71K in Q3 2016. 78 funds tracked by Wall St. Rank hold NERV as of Q4 2016.

  • Acrospire Investment Management reported no remaining Minerva Neurosciences position as of Q4 2016 after selling out during the quarter.
  • Acrospire Investment Management sold 630 Minerva Neurosciences shares in Q4 2016, an estimated $71K.
  • Acrospire Investment Management first reported a position in Minerva Neurosciences in Q2 2016 and held it in 2 quarters.
  • Acrospire Investment Management's Minerva Neurosciences position peaked at $71K in Q3 2016.
  • 78 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2016.

Based on Acrospire Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.